“Regulating medical devices is never a simple thing,” says Shimon Ekhuiz, active chairman and founder of Sofwave Medical, which is traded on the Tel Aviv Stock Exchange with a value of NIS 365 million, after a decrease of about 50% in the past year. “We invested great efforts and money Very much in the planning and execution of in-depth clinical studies, to prove the uniqueness of the revolutionary technology that we wanted to bring to the aesthetic medicine market.
“We worked very hard to get the required regulatory approvals such as the FDA and CE and other regulatory approvals around the world for our technology. In addition, the launch of the product began at the height of the Corona epidemic, which greatly burdened the first steps of our market penetration and building our distribution system in the whole world”.
Sofwave, established in 2015 in the Alon Ventures incubator, deals in the field of medical aesthetics and is based on parallel ultrasound beam technology, approved as mentioned by the FDA and by the CE, as well as by many regulatory authorities in key countries in the world.
“The technology has been proven and proved in clinical trials with leading doctors in the field of aesthetic technology and in intensive daily use. The unique product and technology developed by the company tightens and smooths the skin of the face, reduces the level of wrinkles, allows a change in the appearance of the face and neck by lifting the eyebrows, under the chin and the neck, and improves for a limited period The appearance of cellulite. All these aesthetic results are achieved in a non-invasive treatment that does not harm the outer layer of the patient’s skin. In addition to face and neck treatments, the company is engaged in expanding the clinical uses of its technology to other areas of the body. The company is currently active in the US, Israel, and more than 30 countries in the world,” Shimon elaborates.
Dr. Shimon Ekhuiz is a physicist and entrepreneur in the fields of medicine, internet and communication. Ekhuiz invented over 100 patents. In 2012, he founded the Alon MedTech Ventures incubator, within which a number of companies operate in the fields of minimally invasive surgery, medical aesthetics, and cardiovascular medicine.
“Building our production system was accompanied by significant and not simple challenges due to the global difficulties in the supply chains while rapidly growing the sales of our products,” Shimon shares. “The initial public offering in Tel Aviv in the middle of 2021 secured funding sources that allowed for significant investments in building the distribution systems. We built and produced inventory that enabled the supply of products to the company’s customers and the continued development of the company’s technology in a variety of fields and ways.”
In conclusion, Shimon says that “We plan to continue rapid growth in sales in the coming years while building effective sales channels and, of course, also focusing on developing future products and improving existing products. Sofwave will become the leading company in the aesthetic medical market.”
Self-employed, small business owners and controlling employees – we want to hear from you. To participate in the section, you can contact the email [email protected]